Literature DB >> 2942560

Comparison of T8+ cell-mediated suppressor and cytotoxic functions in multiple sclerosis.

J P Antel, M K Nicholas, M B Bania, A T Reder, B G Arnason, L Joseph.   

Abstract

Patients with progressive multiple sclerosis (MS) and controls were compared with regard to: (a) in vitro pokeweed mitogen (pwm)-induced IgG secretion, as an indirect measure of T8+ cell-mediated suppressor function; (b) alloantigen-directed cytotoxic activity, a predominantly T8+ cell-mediated function. The MS group had increased IgG secretion (4790 +/- 372 ng/ml vs. 1866 +/- 233 ng/ml, P less than 0.001) compared to controls. In contrast, alloantigen-directed cytotoxic activity did not differ between MS and control groups. These results suggest a selective defect of suppressor cell function in MS rather than a generalized dysfunction of T8+ cells. Defective immunoregulatory control coupled with preserved effector functions may contribute to the autoimmune process, suspected to underlie the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942560     DOI: 10.1016/s0165-5728(86)80005-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

Authors:  P J Hughes; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

2.  Evidence for a missed signal to the CD8+ cells in CSF of multiple sclerosis patients.

Authors:  M Saresella; A Grope; L Speciale; R Mancuso; R De Benedictis; D Caputo; P Ferrante
Journal:  Ital J Neurol Sci       Date:  1995-10

Review 3.  TCR peptide therapy in human autoimmune diseases.

Authors:  A A Vandenbark; E Morgan; R Bartholomew; D Bourdette; R Whitham; D Carlo; D Gold; G Hashim; H Offner
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 4.  Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.

Authors:  Luc Van Kaer; Joshua L Postoak; Chuan Wang; Guan Yang; Lan Wu
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

Review 5.  The sad plight of multiple sclerosis research (low on fact, high on fiction): critical data to support it being a neurocristopathy.

Authors:  Peter O Behan; Abhijit Chaudhuri
Journal:  Inflammopharmacology       Date:  2010-09-24       Impact factor: 5.093

Review 6.  CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis.

Authors:  Sushmita Sinha; Alexander W Boyden; Farah R Itani; Michael P Crawford; Nitin J Karandikar
Journal:  Front Immunol       Date:  2015-12-10       Impact factor: 7.561

Review 7.  Multiple sclerosis: possible immunological mechanisms.

Authors:  H F McFarland; S Dhib-Jalbut
Journal:  Clin Immunol Immunopathol       Date:  1989-01

Review 8.  Immunology of multiple sclerosis.

Authors:  H F McFarland
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.